Strategies for Improving Rapid Influenza Testing and Treatment in Ambulatory Settings (SIRAS) | Joint Commission
Follow us on Twitter Friend us on Facebook Vimeo linkedIn Share with your Friends Print this Page
 
Monday 10:35 CST, September 26, 2016

Strategies for Improving Rapid Influenza Testing and Treatment in Ambulatory Settings (SIRAS)

SIRAS

Now available!

  • Updated for the current Flu Season
  • Improved Course Design
    • Four short, 30-minute courses
    •  Free CE credits
    • Ability to view and print transcripts anytime
  • Available on I-pads & Tablets
  • Easy access to videos & resources 
  • Enroll in the course
shareslide1

 

  Did you know?               Enroll Now - Top

  • Seasonal influenza affects 5% to 20% of the population each year in the United States, and is associated with more than 200,000 hospitalizations each year.

  • Healthy people are at risk of complications from influenza too, not just those with chronic illness and vulnerable populations.

  • You do NOT need to order a Rapid Influenza Diagnostic Test (RIDT) for every patient who exhibits flu symptoms in order to make a diagnosis of influenza.

  • Influenza antiviral drugs play an important role in treating flu illnesses.  Early antiviral treatment works best.


How is Your Practice Handling the Flu Season? 

  • Learn WHEN to order a Rapid Influenza Diagnostic Test (RIDT)

  • Know HOW to interpret RIDT results

  • Understand HOW to use local epidemiological information, clinical presentation and RIDT results to assist with the diagnosis and treatment of influenza in your practice setting

  • Learn HOW to properly collect respiratory samples for influenza testing

 Note:


The Joint Commission and the Centers for Disease Control and Prevention would like to thank Copan Diagnostics for their contribution in producing these instructional videos.

This acknowledgement is not an endorsement or recommendation of any specific commercial product by The Joint Commission or the Centers for Disease Control and Prevention.